The pathways discussed and found to be consistently affected by the reported nutraceuticals in breast cancer-Nf-κB, TNF-α/IL-1β, PI3K/Akt, and MAPK/p38-are interconnected and offer the most relevant molecular targets for therapeutic protocols. Here, IL1B is linked to breast carcinoma.